Clinical Trial Update: Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase I/II adaptive randomized trial comparing bevacizumab alone versus bevacizumab plus vorinostat in adults with recurrent glioblastoma; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Malignant Glioma, Recurrent Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-09-23